Vanguard U.S. Value Factor ETF (VFVA)
BATS: VFVA · IEX Real-Time Price · USD
107.44 1.05 (0.99%)
Jan 20, 2022 11:21 AM EST - Market open
| Assets | $500.03M |
| NAV | $106.39 |
| Expense Ratio | 0.14% |
| PE Ratio | 11.80 |
| Shares Out | 4.70M |
| Dividend (ttm) | $1.77 |
| Dividend Yield | 1.65% |
| Ex-Dividend Date | Dec 27, 2021 |
| 1-Year Return | +27.64% |
| Volume | 7,748 |
| Open | 106.84 |
| Previous Close | 106.39 |
| Day's Range | 106.02 - 107.65 |
| 52-Week Low | 79.06 |
| 52-Week High | 79.06 |
| Beta | 1.39 |
| Holdings | 823 |
| Inception Date | Feb 13, 2018 |
About VFVA
The fund invests primarily in U.S. common stocks with the potential to generate higher returns relative to the broad U.S. equity market by investing in stocks with relatively lower share prices relative to fundamental values as determined by the advisor. Under normal circumstances, at least 80% of the fund's assets will be invested in securities issued by U.S. companies.
Asset ClassEquity
RegionNorth America
IssuerVanguard Group
Stock ExchangeBATS
Ticker SymbolVFVA
Index TrackedCRSP U.S. Large Cap Value Index
Top 10 Holdings
8.64% of assets| Name | Symbol | Weight |
|---|---|---|
| AT&T, Inc. | T | 1.27% |
| FedEx | FDX | 1.02% |
| Ford Motor Company | F | 0.90% |
| Verizon Communications | VZ | 0.87% |
| Cigna | CI | 0.83% |
| General Motors Company | GM | 0.81% |
| CVS Health | CVS | 0.79% |
| Bristol-Myers Squibb Company | BMY | 0.75% |
| Centene | CNC | 0.71% |
| Dow Inc. | DOW | 0.69% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 27, 2021 | $0.5659 | Dec 30, 2021 |
| Sep 24, 2021 | $0.4573 | Sep 29, 2021 |
| Jun 29, 2021 | $0.4084 | Jul 2, 2021 |
| Mar 22, 2021 | $0.3389 | Mar 25, 2021 |
| Dec 24, 2020 | $0.4828 | Dec 30, 2020 |
| Sep 21, 2020 | $0.3535 | Sep 24, 2020 |
News
Reasons to Bet on High Beta ETFs & Stocks
The momentum was driven by a vaccine development, which is being viewed as "a beginning to the end" of the coronavirus pandemic, and the prospect of divided congress, which is considered favorable for t...
1 year ago - Zacks Investment Research
5 High-Beta ETFs & Stocks for a Record Market
While every corner of the market is enjoying the current ascent, high-beta ETFs and stocks seem a perfect bet at present.
2 years ago - Zacks Investment Research